Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Robotics and Aseptic Processing in View of Regulatory Requirements.
Andrea Tanzini1, Marco Ruggeri2, Eleonora Bianchi2
1Staubli Robotics, Staubli Italia S.p.A, Via Rivera 55, 20841 Carate Brianza, Italy.
The COVID-19 pandemic accelerated nanomedicine production, highlighting the need for continuous manufacturing. Robotics and automation are poised to revolutionize pharmaceutical Good Manufacturing Practice (GMP) and aseptic manufacturing within five years.
Area of Science:
- Pharmaceutical Manufacturing
- Nanomedicine
- Regulatory Science
Background:
- The COVID-19 pandemic spurred the market entry of nanomedicine products, emphasizing scalability and reproducibility challenges.
- Traditional pharmaceutical manufacturing, heavily regulated, faces pressure to adopt advanced technologies for improved efficiency.
- The European Medicines Agency (EMA) is actively promoting process enhancements through established industrial technologies.
Purpose of the Study:
- To analyze regulatory shifts impacting aseptic manufacturing.
- To explore the integration of robotics in pharmaceutical settings to meet Good Manufacturing Practice (GMP) standards.
- To bridge the knowledge gap between pharmaceutical technologists and engineers regarding automation and regulation.
Main Methods:
- Review of regulatory changes in pharmaceutical manufacturing, particularly aseptic processes.
- Examination of robotics and automation technologies applicable to the pharmaceutical industry.
- Analysis of the potential impact of these technologies on process efficiency and contamination reduction.
Main Results:
- Robotics is identified as a key technological driver for significant changes in pharmaceutical manufacturing within the next five years.
- Implementation of robotics and automation is expected to enhance process efficiency and minimize contamination risks, especially in aseptic environments.
- Regulatory frameworks are evolving to accommodate advanced manufacturing technologies.
Conclusions:
- The pharmaceutical industry is undergoing a cultural shift towards adopting robotics and automation for continuous production.
- This transition is crucial for addressing scalability and reproducibility issues in nanomedicine manufacturing.
- A common understanding of regulatory and technological aspects is essential for successful implementation.
Related Concept Videos
Asepsis
Key Techniques in Microbiology
Cleaning, Sterilization, and Disinfection
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
Need for Obtaining Pure Cultures
Methods for Controlling Microbial Growth

